Evaluation of poly(L-lactide) and chitosan composite scaffolds for cartilage tissue regeneration

Show simple item record

dc.contributor.author Mallick, Sarada Prasanna
dc.contributor.author Pal, Kunal
dc.contributor.author Rastogi, Amit
dc.contributor.author Srivastava, Pradeep
dc.date.accessioned 2020-02-24T11:21:35Z
dc.date.available 2020-02-24T11:21:35Z
dc.date.issued 2016-02-01
dc.identifier.issn 1385772X
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/651
dc.description.abstract The present study delineates the development of chitosan and poly(L-lactide) (PLLA) scaffolds cross-linked using a mixture of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), n-hydroxysuccinimide (NHS), and chondroitin sulfate (CS) for cartilage tissue engineering applications. Chitosan and PLLA were varied in concentration for developing scaffolds and prepared by freeze-drying method. The various scaffolds were studied using scanning electron microscopy (SEM), porosity by mercury intrusion porosimeter, and the molecular interactions among polymers using Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) studies. Differential scanning calorimetry was used to predict the thermal properties of the scaffolds. The mechanical properties of the scaffolds were studied using static mechanical tester. The ability of the scaffolds to support chondrocyte proliferation was also studied. The microscopy suggests that the pore size of the scaffolds varied with the composition in the range of 38-172 m and the porosities in the range of 73-93%. The XRD and the FTIR studies suggested that an alternation in the composition of the scaffolds altered the molecular interactions among the scaffold components. An increase in the chitosan content enhanced the swelling property. The degradation of the scaffolds was least when the proportion of chitosan and PLLA was in the ratio of 70:30. The in vitro cell proliferation study suggested that the developed scaffolds were able to support chondrogenesis, the glycosaminoglycan (GAG) content of the mature chondrocyte was 40 g/ml and the viability was approximately 90%. Hence, the so designed scaffolds may be tried for cartilage tissue engineering applications. en_US
dc.language.iso en_US en_US
dc.publisher Taylor and Francis Ltd. en_US
dc.subject chondrocyte en_US
dc.subject chondrogenesis en_US
dc.subject freezedrying en_US
dc.subject glycosaminoglycans en_US
dc.subject PLLA en_US
dc.subject scaffold en_US
dc.title Evaluation of poly(L-lactide) and chitosan composite scaffolds for cartilage tissue regeneration en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account